Skip to main content Skip to footer
HomeHome
 
  • Homepage
  • Searching for patents

    Patent knowledge

    Access our patent databases and search tools.

    Go to overview 

    • Overview
    • Technical information
      • Overview
      • Espacenet - patent search
      • European Publication Server
      • EP full-text search
    • Legal information
      • Overview
      • European Patent Register
      • European Patent Bulletin
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Overview
      • PATSTAT
      • IPscore
      • Technology insight reports
    • Data
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
      • Web services
      • Coverage, codes and statistics
    • Technology platforms
      • Overview
      • Plastics in transition
      • Water innovation
      • Space innovation
      • Technologies combatting cancer
      • Firefighting technologies
      • Clean energy technologies
      • Fighting coronavirus
    • Helpful resources
      • Overview
      • First time here?
      • Asian patent information
      • Patent information centres
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
    Image
    Plastics in Transition

    Technology insight report on plastic waste management

  • Applying for a patent

    Applying for a patent

    Practical information on filing and grant procedures.

    Go to overview 

    • Overview
    • European route
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
      • Appeals
      • Unitary Patent & Unified Patent Court
      • National validation
      • Request for extension/validation
    • International route (PCT)
      • Overview
      • Euro-PCT Guide – PCT procedure at the EPO
      • EPO decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
      • Training and events
    • National route
    • Find a professional representative
    • MyEPO services
      • Overview
      • Understand our services
      • Get access
      • File with us
      • Interact with us on your files
      • Online Filing & fee payment outages
    • Forms
      • Overview
      • Request for examination
    • Fees
      • Overview
      • European fees (EPC)
      • International fees (PCT)
      • Unitary Patent fees (UP)
      • Fee payment and refunds
      • Warning

    UP

    Find out how the Unitary Patent can enhance your IP strategy

  • Law & practice

    Law & practice

    European patent law, the Official Journal and other legal texts.

    Go to overview 

    • Overview
    • Legal texts
      • Overview
      • European Patent Convention
      • Official Journal
      • Guidelines
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
      • Unitary patent system
      • National measures relating to the Unitary Patent
    • Court practices
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
    Image
    Law and practice scales 720x237

    Keep up with key aspects of selected BoA decisions with our monthly "Abstracts of decisions”

  • News & events

    News & events

    Our latest news, podcasts and events, including the European Inventor Award.

    Go to overview 

     

    • Overview
    • News
    • Events
    • European Inventor Award
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the finalists
      • Nominations
      • European Inventor Network
      • The 2024 event
    • Young Inventor Prize
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
    • Press centre
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • Innovation and patenting in focus
      • Overview
      • Water-related technologies
      • CodeFest
      • Green tech in focus
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
      • The future of medicine
      • Materials science
      • Mobile communications
      • Biotechnology
      • Patent classification
      • Digital technologies
      • The future of manufacturing
      • Books by EPO experts
    • "Talk innovation" podcast

    Podcast

    From ideas to inventions: tune into our podcast for the latest in tech and IP

  • Learning

    Learning

    The European Patent Academy – the point of access to your learning

    Go to overview 

    • Overview
    • Learning activities and paths
      • Overview
      • Learning activities
      • Learning paths
    • EQE and EPAC
      • Overview
      • EQE - European qualifying examination
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Overview
      • Business and IP managers
      • EQE and EPAC Candidates
      • Judges, lawyers and prosecutors
      • National offices and IP authorities
      • Patent attorneys and paralegals
      • Universities, research centres and technology transfer centres (TTOs)
    Image
    Patent Academy catalogue

    Have a look at the extensive range of learning opportunities in the European Patent Academy training catalogue

  • About us

    About us

    Find out more about our work, values, history and vision

    Go to overview 

    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Overview
      • Official celebrations
      • Member states’ video statements
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Overview
      • Legal foundations
      • Member states of the European Patent Organisation
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Overview
      • Communiqués
      • Calendar
      • Documents and publications
      • Administrative Council
    • Principles & strategy
      • Overview
      • Our mission, vision, values and corporate policy
      • Strategic Plan 2028
      • Towards a New Normal
    • Leadership & management
      • Overview
      • President António Campinos
      • Management Advisory Committee
    • Sustainability at the EPO
      • Overview
      • Environmental
      • Social
      • Governance and Financial sustainability
    • Services & activities
      • Overview
      • Our services & structure
      • Quality
      • Consulting our users
      • European and international co-operation
      • European Patent Academy
      • Chief Economist
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Overview
      • Innovation actors
      • Policy and funding
      • Tools
      • About the Observatory
    • Procurement
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Sustainable Procurement Policy
      • About eTendering and electronic signatures
      • Procurement portal
      • Invoicing
      • General conditions
      • Archived tenders
    • Transparency portal
      • Overview
      • General
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
      • "Long Night"
    Image
    Patent Index 2024 keyvisual showing brightly lit up data chip, tinted in purple, bright blue

    Track the latest tech trends with our Patent Index

 
en de fr
  • Language selection
  • English
  • Deutsch
  • Français
Main navigation
  • Homepage
    • Go back
    • New to patents
  • New to patents
    • Go back
    • Your business and patents
    • Why do we have patents?
    • What's your big idea?
    • Are you ready?
    • What to expect
    • How to apply for a patent
    • Is it patentable?
    • Are you first?
    • Patent quiz
    • Unitary patent video
  • Searching for patents
    • Go back
    • Overview
    • Technical information
      • Go back
      • Overview
      • Espacenet - patent search
        • Go back
        • Overview
        • National patent office databases
        • Global Patent Index (GPI)
        • Release notes
      • European Publication Server
        • Go back
        • Overview
        • Release notes
        • Cross-reference index for Euro-PCT applications
        • EP authority file
        • Help
      • EP full-text search
    • Legal information
      • Go back
      • Overview
      • European Patent Register
        • Go back
        • Overview
        • Release notes archive
        • Register documentation
          • Go back
          • Overview
          • Deep link data coverage
          • Federated Register
          • Register events
      • European Patent Bulletin
        • Go back
        • Overview
        • Download Bulletin
        • EP Bulletin search
        • Help
      • European Case Law Identifier sitemap
      • Third-party observations
    • Business information
      • Go back
      • Overview
      • PATSTAT
      • IPscore
        • Go back
        • Release notes
      • Technology insight reports
    • Data
      • Go back
      • Overview
      • Technology Intelligence Platform
      • Linked open EP data
      • Bulk data sets
        • Go back
        • Overview
        • Manuals
        • Sequence listings
        • National full-text data
        • European Patent Register data
        • EPO worldwide bibliographic data (DOCDB)
        • EP full-text data
        • EPO worldwide legal event data (INPADOC)
        • EP bibliographic data (EBD)
        • Boards of Appeal decisions
      • Web services
        • Go back
        • Overview
        • Open Patent Services (OPS)
        • European Publication Server web service
      • Coverage, codes and statistics
        • Go back
        • Weekly updates
        • Updated regularly
    • Technology platforms
      • Go back
      • Overview
      • Plastics in transition
        • Go back
        • Overview
        • Plastics waste recovery
        • Plastics waste recycling
        • Alternative plastics
      • Innovation in water technologies
        • Go back
        • Overview
        • Clean water
        • Protection from water
      • Space innovation
        • Go back
        • Overview
        • Cosmonautics
        • Space observation
      • Technologies combatting cancer
        • Go back
        • Overview
        • Prevention and early detection
        • Diagnostics
        • Therapies
        • Wellbeing and aftercare
      • Firefighting technologies
        • Go back
        • Overview
        • Detection and prevention of fires
        • Fire extinguishing
        • Protective equipment
        • Post-fire restoration
      • Clean energy technologies
        • Go back
        • Overview
        • Renewable energy
        • Carbon-intensive industries
        • Energy storage and other enabling technologies
      • Fighting coronavirus
        • Go back
        • Overview
        • Vaccines and therapeutics
          • Go back
          • Overview
          • Vaccines
          • Overview of candidate therapies for COVID-19
          • Candidate antiviral and symptomatic therapeutics
          • Nucleic acids and antibodies to fight coronavirus
        • Diagnostics and analytics
          • Go back
          • Overview
          • Protein and nucleic acid assays
          • Analytical protocols
        • Informatics
          • Go back
          • Overview
          • Bioinformatics
          • Healthcare informatics
        • Technologies for the new normal
          • Go back
          • Overview
          • Devices, materials and equipment
          • Procedures, actions and activities
          • Digital technologies
        • Inventors against coronavirus
    • Helpful resources
      • Go back
      • Overview
      • First time here?
        • Go back
        • Overview
        • Basic definitions
        • Patent classification
          • Go back
          • Overview
          • Cooperative Patent Classification (CPC)
        • Patent families
          • Go back
          • Overview
          • DOCDB simple patent family
          • INPADOC extended patent family
        • Legal event data
          • Go back
          • Overview
          • INPADOC classification scheme
      • Asian patent information
        • Go back
        • Overview
        • China (CN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Chinese Taipei (TW)
          • Go back
          • Overview
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • India (IN)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
        • Japan (JP)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Korea (KR)
          • Go back
          • Overview
          • Facts and figures
          • Grant procedure
          • Numbering system
          • Useful terms
          • Searching in databases
        • Russian Federation (RU)
          • Go back
          • Overview
          • Facts and figures
          • Numbering system
          • Searching in databases
        • Useful links
      • Patent information centres (PATLIB)
      • Patent Translate
      • Patent Knowledge News
      • Business and statistics
      • Unitary Patent information in patent knowledge
  • Applying for a patent
    • Go back
    • Overview
    • European route
      • Go back
      • Overview
      • European Patent Guide
      • Oppositions
      • Oral proceedings
        • Go back
        • Oral proceedings calendar
          • Go back
          • Calendar
          • Public access to appeal proceedings
          • Public access to opposition proceedings
          • Technical guidelines
      • Appeals
      • Unitary Patent & Unified Patent Court
        • Go back
        • Overview
        • Unitary Patent
          • Go back
          • Overview
          • Legal framework
          • Main features
          • Applying for a Unitary Patent
          • Cost of a Unitary Patent
          • Translation and compensation
          • Start date
          • Introductory brochures
        • Unified Patent Court
      • National validation
      • Extension/validation request
    • International route
      • Go back
      • Overview
      • Euro-PCT Guide
      • Entry into the European phase
      • Decisions and notices
      • PCT provisions and resources
      • Extension/validation request
      • Reinforced partnership programme
      • Accelerating your PCT application
      • Patent Prosecution Highway (PPH)
        • Go back
        • Patent Prosecution Highway (PPH) programme outline
      • Training and events
    • National route
    • MyEPO services
      • Go back
      • Overview
      • Understand our services
        • Go back
        • Overview
        • Exchange data with us using an API
          • Go back
          • Release notes
      • Get access
        • Go back
        • Overview
        • Release notes
      • File with us
        • Go back
        • Overview
        • What if our online filing services are down?
        • Release notes
      • Interact with us on your files
        • Go back
        • Release notes
      • Online Filing & fee payment outages
    • Fees
      • Go back
      • Overview
      • European fees (EPC)
        • Go back
        • Overview
        • Decisions and notices
      • International fees (PCT)
        • Go back
        • Reduction in fees
        • Fees for international applications
        • Decisions and notices
        • Overview
      • Unitary Patent fees (UP)
        • Go back
        • Overview
        • Decisions and notices
      • Fee payment and refunds
        • Go back
        • Overview
        • Payment methods
        • Getting started
        • FAQs and other documentation
        • Technical information for batch payments
        • Decisions and notices
        • Release notes
      • Warning
    • Forms
      • Go back
      • Overview
      • Request for examination
    • Find a professional representative
  • Law & practice
    • Go back
    • Overview
    • Legal texts
      • Go back
      • Overview
      • European Patent Convention
        • Go back
        • Overview
        • Archive
          • Go back
          • Overview
          • Documentation on the EPC revision 2000
            • Go back
            • Overview
            • Diplomatic Conference for the revision of the EPC
            • Travaux préparatoires
            • New text
            • Transitional provisions
            • Implementing regulations to the EPC 2000
            • Rules relating to Fees
            • Ratifications and accessions
          • Travaux Préparatoires EPC 1973
      • Official Journal
      • Guidelines
        • Go back
        • Overview
        • EPC Guidelines
        • PCT-EPO Guidelines
        • Unitary Patent Guidelines
        • Guidelines revision cycle
        • Consultation results
        • Summary of user responses
        • Archive
      • Extension / validation system
      • London Agreement
      • National law relating to the EPC
        • Go back
        • Overview
        • Archive
      • Unitary Patent system
        • Go back
        • Travaux préparatoires to UP and UPC
      • National measures relating to the Unitary Patent 
    • Court practices
      • Go back
      • Overview
      • European Patent Judges' Symposium
    • User consultations
      • Go back
      • Overview
      • Ongoing consultations
      • Completed consultations
    • Substantive patent law harmonisation
      • Go back
      • Overview
      • The Tegernsee process
      • Group B+
    • Convergence of practice
    • Options for professional representatives
  • News & events
    • Go back
    • Overview
    • News
    • Events
    • European Inventor Award
      • Go back
      • Overview
      • The meaning of tomorrow
      • About the award
      • Categories and prizes
      • Meet the inventors
      • Nominations
      • European Inventor Network
        • Go back
        • 2024 activities
        • 2025 activities
        • Rules and criteria
        • FAQ
      • The 2024 event
    • Young Inventors Prize
      • Go back
      • Overview
      • About the prize
      • Nominations
      • The jury
      • The world, reimagined
      • The 2025 event
    • Press centre
      • Go back
      • Overview
      • Patent Index and statistics
      • Search in press centre
      • Background information
        • Go back
        • Overview
        • European Patent Office
        • Q&A on patents related to coronavirus
        • Q&A on plant patents
      • Copyright
      • Press contacts
      • Call back form
      • Email alert service
    • In focus
      • Go back
      • Overview
      • Water-related technologies
      • CodeFest
        • Go back
        • CodeFest Spring 2025 on classifying patent data for sustainable development
        • Overview
        • CodeFest 2024 on generative AI
        • CodeFest 2023 on Green Plastics
      • Green tech in focus
        • Go back
        • Overview
        • About green tech
        • Renewable energies
        • Energy transition technologies
        • Building a greener future
      • Research institutes
      • Women inventors
      • Lifestyle
      • Space and satellites
        • Go back
        • Overview
        • Patents and space technologies
      • Healthcare
        • Go back
        • Overview
        • Medical technologies and cancer
        • Personalised medicine
      • Materials science
        • Go back
        • Overview
        • Nanotechnology
      • Mobile communications
      • Biotechnology
        • Go back
        • Overview
        • Red, white or green
        • The role of the EPO
        • What is patentable?
        • Biotech inventors
      • Classification
        • Go back
        • Overview
        • Nanotechnology
        • Climate change mitigation technologies
          • Go back
          • Overview
          • External partners
          • Updates on Y02 and Y04S
      • Digital technologies
        • Go back
        • Overview
        • About ICT
        • Hardware and software
        • Artificial intelligence
        • Fourth Industrial Revolution
      • Additive manufacturing
        • Go back
        • Overview
        • About AM
        • AM innovation
      • Books by EPO experts
    • Podcast
  • Learning
    • Go back
    • Overview
    • Learning activities and paths
      • Go back
      • Overview
      • Learning activities: types and formats
      • Learning paths
    • EQE and EPAC
      • Go back
      • Overview
      • EQE - European Qualifying Examination
        • Go back
        • Overview
        • Compendium
          • Go back
          • Overview
          • Paper F
          • Paper A
          • Paper B
          • Paper C
          • Paper D
          • Pre-examination
        • Candidates successful in the European qualifying examination
        • Archive
      • EPAC - European patent administration certification
      • CSP – Candidate Support Programme
    • Learning resources by area of interest
      • Go back
      • Overview
      • Patent granting
      • Technology transfer and dissemination
      • Patent enforcement and litigation
    • Learning resources by profile
      • Go back
      • Overview
      • Business and IP managers
        • Go back
        • Overview
        • Innovation case studies
          • Go back
          • Overview
          • SME case studies
          • Technology transfer case studies
          • High-growth technology case studies
        • Inventor's handbook
          • Go back
          • Overview
          • Introduction
          • Disclosure and confidentiality
          • Novelty and prior art
          • Competition and market potential
          • Assessing the risk ahead
          • Proving the invention
          • Protecting your idea
          • Building a team and seeking funding
          • Business planning
          • Finding and approaching companies
          • Dealing with companies
        • Best of search matters
          • Go back
          • Overview
          • Tools and databases
          • EPO procedures and initiatives
          • Search strategies
          • Challenges and specific topics
        • Support for high-growth technology businesses
          • Go back
          • Overview
          • Business decision-makers
          • IP professionals
          • Stakeholders of the Innovation Ecosystem
      • EQE and EPAC Candidates
        • Go back
        • Overview
        • Paper F brain-teasers
        • Daily D questions
        • European qualifying examination - Guide for preparation
        • EPAC
      • Judges, lawyers and prosecutors
        • Go back
        • Overview
        • Compulsory licensing in Europe
        • The jurisdiction of European courts in patent disputes
      • National offices and IP authorities
        • Go back
        • Overview
        • Learning material for examiners of national officers
        • Learning material for formalities officers and paralegals
      • Patent attorneys and paralegals
      • Universities, research centres and TTOs
        • Go back
        • Overview
        • Modular IP Education Framework (MIPEF)
        • Pan-European Seal Young Professionals Programme
          • Go back
          • Overview
          • For students
          • For universities
            • Go back
            • Overview
            • IP education resources
            • University memberships
          • Our young professionals
          • Professional development plan
        • Academic Research Programme
          • Go back
          • Overview
          • Completed research projects
          • Current research projects
        • IP Teaching Kit
          • Go back
          • Overview
          • Download modules
        • Intellectual property course design manual
        • PATLIB Knowledge Transfer to Africa
          • Go back
          • The PATLIB Knowledge Transfer to Africa initiative (KT2A)
          • KT2A core activities
          • Success story: Malawi University of Science and Technology and PATLIB Birmingham
  • About us
    • Go back
    • Overview
    • The EPO at a glance
    • 50 years of the EPC
      • Go back
      • Official celebrations
      • Overview
      • Member states’ video statements
        • Go back
        • Albania
        • Austria
        • Belgium
        • Bulgaria
        • Croatia
        • Cyprus
        • Czech Republic
        • Denmark
        • Estonia
        • Finland
        • France
        • Germany
        • Greece
        • Hungary
        • Iceland
        • Ireland
        • Italy
        • Latvia
        • Liechtenstein
        • Lithuania
        • Luxembourg
        • Malta
        • Monaco
        • Montenegro
        • Netherlands
        • North Macedonia
        • Norway
        • Poland
        • Portugal
        • Romania
        • San Marino
        • Serbia
        • Slovakia
        • Slovenia
        • Spain
        • Sweden
        • Switzerland
        • Türkiye
        • United Kingdom
      • 50 Leading Tech Voices
      • Athens Marathon
      • Kids’ collaborative art competition
    • Legal foundations and member states
      • Go back
      • Overview
      • Legal foundations
      • Member states
        • Go back
        • Overview
        • Member states by date of accession
      • Extension states
      • Validation states
    • Administrative Council and subsidiary bodies
      • Go back
      • Overview
      • Communiqués
        • Go back
        • 2024
        • Overview
        • 2023
        • 2022
        • 2021
        • 2020
        • 2019
        • 2018
        • 2017
        • 2016
        • 2015
        • 2014
        • 2013
      • Calendar
      • Documents and publications
        • Go back
        • Overview
        • Select Committee documents
      • Administrative Council
        • Go back
        • Overview
        • Composition
        • Representatives
        • Rules of Procedure
        • Board of Auditors
        • Secretariat
        • Council bodies
    • Principles & strategy
      • Go back
      • Overview
      • Mission, vision, values & corporate policy
      • Strategic Plan 2028
        • Go back
        • Driver 1: People
        • Driver 2: Technologies
        • Driver 3: High-quality, timely products and services
        • Driver 4: Partnerships
        • Driver 5: Financial sustainability
      • Towards a New Normal
      • Data protection & privacy notice
    • Leadership & management
      • Go back
      • Overview
      • About the President
      • Management Advisory Committee
    • Sustainability at the EPO
      • Go back
      • Overview
      • Environmental
        • Go back
        • Overview
        • Inspiring environmental inventions
      • Social
        • Go back
        • Overview
        • Inspiring social inventions
      • Governance and Financial sustainability
    • Procurement
      • Go back
      • Overview
      • Procurement forecast
      • Doing business with the EPO
      • Procurement procedures
      • Dynamic Purchasing System (DPS) publications
      • Sustainable Procurement Policy
      • About eTendering
      • Invoicing
      • Procurement portal
        • Go back
        • Overview
        • e-Signing contracts
      • General conditions
      • Archived tenders
    • Services & activities
      • Go back
      • Overview
      • Our services & structure
      • Quality
        • Go back
        • Overview
        • Foundations
          • Go back
          • Overview
          • European Patent Convention
          • Guidelines for examination
          • Our staff
        • Enabling quality
          • Go back
          • Overview
          • Prior art
          • Classification
          • Tools
          • Processes
        • Products & services
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
          • Continuous improvement
        • Quality through networking
          • Go back
          • Overview
          • User engagement
          • Co-operation
          • User satisfaction survey
          • Stakeholder Quality Assurance Panels
        • Patent Quality Charter
        • Quality Action Plan
        • Quality dashboard
        • Statistics
          • Go back
          • Overview
          • Search
          • Examination
          • Opposition
        • Integrated management at the EPO
      • Consulting our users
        • Go back
        • Overview
        • Standing Advisory Committee before the EPO (SACEPO)
          • Go back
          • Overview
          • Objectives
          • SACEPO and its working parties
          • Meetings
          • Single Access Portal – SACEPO Area
        • Surveys
          • Go back
          • Overview
          • Detailed methodology
          • Search services
          • Examination services, final actions and publication
          • Opposition services
          • Formalities services
          • Customer services
          • Filing services
          • Key Account Management (KAM)
          • Website
          • Archive
      • Our user service charter
      • European and international co-operation
        • Go back
        • Overview
        • Co-operation with member states
          • Go back
          • Overview
        • Bilateral co-operation with non-member states
          • Go back
          • Overview
          • Validation system
          • Reinforced Partnership programme
        • Multilateral international co-operation with IP offices and organisations
        • Co-operation with international organisations outside the IP system
      • European Patent Academy
        • Go back
        • Overview
        • Partners
      • Chief Economist
        • Go back
        • Overview
        • Economic studies
      • Ombuds Office
      • Reporting wrongdoing
    • Observatory on Patents and Technology
      • Go back
      • Overview
      • Innovation against cancer
      • Innovation actors
        • Go back
        • Overview
        • Startups and SMEs
      • Policy and funding
        • Go back
        • Overview
        • Financing innovation programme
          • Go back
          • Overview
          • Our studies on the financing of innovation
          • EPO initiatives for patent applicants
          • Financial support for innovators in Europe
        • Patents and standards
          • Go back
          • Overview
          • Publications
          • Patent standards explorer
      • Tools
        • Go back
        • Overview
        • Deep Tech Finder
      • About the Observatory
        • Go back
        • Overview
        • Work plan
    • Transparency portal
      • Go back
      • Overview
      • General
        • Go back
        • Overview
        • Annual Review 2023
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • 50 years of the EPC
          • Strategic key performance indicators
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
        • Annual Review 2022
          • Go back
          • Overview
          • Foreword
          • Executive summary
          • Goal 1: Engaged and empowered
          • Goal 2: Digital transformation
          • Goal 3: Master quality
          • Goal 4: Partner for positive impact
          • Goal 5: Secure sustainability
      • Human
      • Environmental
      • Organisational
      • Social and relational
      • Economic
      • Governance
    • Statistics and trends
      • Go back
      • Overview
      • Statistics & Trends Centre
      • Patent Index 2024
        • Go back
        • Insight into computer technology and AI
        • Insight into clean energy technologies
        • Statistics and indicators
          • Go back
          • European patent applications
            • Go back
            • Key trend
            • Origin
            • Top 10 technical fields
              • Go back
              • Computer technology
              • Electrical machinery, apparatus, energy
              • Digital communication
              • Medical technology
              • Transport
              • Measurement
              • Biotechnology
              • Pharmaceuticals
              • Other special machines
              • Organic fine chemistry
            • All technical fields
          • Applicants
            • Go back
            • Top 50
            • Categories
            • Women inventors
          • Granted patents
            • Go back
            • Key trend
            • Origin
            • Designations
      • Data to download
      • EPO Data Hub
      • Clarification on data sources
    • History
      • Go back
      • Overview
      • 1970s
      • 1980s
      • 1990s
      • 2000s
      • 2010s
      • 2020s
    • Art collection
      • Go back
      • Overview
      • The collection
      • Let's talk about art
      • Artists
      • Media library
      • What's on
      • Publications
      • Contact
      • Culture Space A&T 5-10
        • Go back
        • Catalyst lab & Deep vision
          • Go back
          • Irene Sauter (DE)
          • AVPD (DK)
          • Jan Robert Leegte (NL)
          • Jānis Dzirnieks (LV) #1
          • Jānis Dzirnieks (LV) #2
          • Péter Szalay (HU)
          • Thomas Feuerstein (AT)
          • Tom Burr (US)
          • Wolfgang Tillmans (DE)
          • TerraPort
          • Unfinished Sculpture - Captives #1
          • Deep vision – immersive exhibition
          • Previous exhibitions
        • The European Patent Journey
        • Sustaining life. Art in the climate emergency
        • Next generation statements
        • Open storage
        • Cosmic bar
      • "Long Night"
  • Boards of Appeal
    • Go back
    • Overview
    • Decisions of the Boards of Appeal
      • Go back
      • Overview
      • Recent decisions
      • Selected decisions
    • Information from the Boards of Appeal
    • Procedure
    • Oral proceedings
    • About the Boards of Appeal
      • Go back
      • Overview
      • President of the Boards of Appeal
      • Enlarged Board of Appeal
        • Go back
        • Overview
        • Pending referrals (Art. 112 EPC)
        • Decisions sorted by number (Art. 112 EPC)
        • Pending petitions for review (Art. 112a EPC)
        • Decisions on petitions for review (Art. 112a EPC)
      • Technical Boards of Appeal
      • Legal Board of Appeal
      • Disciplinary Board of Appeal
      • Presidium
        • Go back
        • Overview
    • Code of Conduct
    • Business distribution scheme
      • Go back
      • Overview
      • Technical boards of appeal by IPC in 2025
      • Archive
    • Annual list of cases
    • Communications
    • Annual reports
      • Go back
      • Overview
    • Publications
      • Go back
      • Abstracts of decisions
    • Case Law of the Boards of Appeal
      • Go back
      • Overview
      • Archive
  • Service & support
    • Go back
    • Overview
    • Website updates
    • Availability of online services
      • Go back
      • Overview
    • FAQ
      • Go back
      • Overview
    • Publications
    • Ordering
      • Go back
      • Overview
      • Patent Knowledge Products and Services
      • Terms and conditions
        • Go back
        • Overview
        • Patent information products
        • Bulk data sets
        • Open Patent Services (OPS)
        • Fair use charter
    • Procedural communications
    • Useful links
      • Go back
      • Overview
      • Patent offices of member states
      • Other patent offices
      • Directories of patent attorneys
      • Patent databases, registers and gazettes
      • Disclaimer
    • Contact us
      • Go back
      • Overview
      • Filing options
      • Locations
    • Subscription centre
      • Go back
      • Overview
      • Subscribe
      • Change preferences
      • Unsubscribe
    • Official holidays
    • Glossary
    • RSS feeds
Board of Appeals
Decisions

Recent decisions

Overview
  • 2025 decisions
  • 2024 decisions
  • 2023 decisions
  1. Home
  2. T 0815/90 (Hepatitis A virus II) 20-10-1997
Facebook X Linkedin Email

T 0815/90 (Hepatitis A virus II) 20-10-1997

European Case Law Identifier
ECLI:EP:BA:1997:T081590.19971020
Date of decision
20 October 1997
Case number
T 0815/90
Petition for review of
-
Application number
85904746.6
IPC class
C12N 7/08
Language of proceedings
EN
Distribution
DISTRIBUTED TO BOARD CHAIRMEN AND MEMBERS (B)

Download and more information:

Decision in EN 561.35 KB
Documentation of the appeal procedure can be found in the European Patent Register
Bibliographic information is available in:
EN
Versions
OJ
Published
Unpublished
Application title

Hepatitis A virus purified and triply cloned

Applicant name
THE UNITED STATES OF AMERICA - Department of Commerce
Opponent name
-
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2) 1973
European Patent Convention R 28 1973
European Patent Convention R 28(1)(c) 1973
European Patent Convention R 28(2)(a) 1973
Patent Cooperation Treaty R 13a
Keywords
Subject-matter other than accession number added in relation to deposited material - not allowable under Article 123(2) EPC or Rule 28 EPC
Catchword
-
Cited decisions
G 0002/93
J 0008/87
T 0815/90
Citing decisions
J 0027/94
T 0083/05
J 0027/94
J 0027/94
T 1014/01
T 0083/05
T 0083/05
T 2068/11
T 0815/90
J 0027/94
T 0083/05

I. European patent application No. 85 904 746.6 filed on 18. September 1985, claiming priority of 19 September 1984 was published under No. WO-A-86/01826 with seven claims.

II. The text of the application as filed contained the following passages:

"Statement of deposit

The HM-175 strain of hepatitis A virus has been deposited in the American Type Culture Collection under the patent procedures prior to the filing of this application, thus affording permanency of the deposit and ready availability to the public upon issuance of a patent."

(appearing immediately before Example 1 three lines reading as follows:)

"The HM-175 strain of human hepatitis A virus was imported into this country and is described in Infection and Immunity, 32(1), April 1981, pages 388-393."

"Example 3

....Clone #1 (TC passage 20 or 21) infected 11 of 15 susceptible chimpanzees inoculated intravenously or by mouth and produced a mild hepatitis in only two of these. The 11 infected chimpanzees responded with protective antibody 3-8 weeks after vaccination. Clone #2 (TC passage 20) was inoculated intravenously into 4 susceptible chimpanzees. Only 1 of the 4 animals had a very mild borderline hepatitis. All four developed protective antibody. Similarly, 1 of 2 susceptible chimpanzees inoculated intravenously with clone #4 (TC passage 9) was infected without hepatitis but with the development of protective antibody."

The claims as originally filed read:

"1. A method of producing a protective antibody response in higher primates by injecting said primate with a hepatitis A live attenuated virus injection which is of uniform virus composition.

2. The method of claim 1, wherein the uniform virus composition is triple cloned material of passage level at least 10-30.

3. The method of claim 1, wherein the live attenuated virus is strain HM-175.

4. The method of claim 1, wherein the injection of a higher primate is a form of vaccination that confers protection against type A hepatitis caused by unmodified (wild type) hepatitis A virus.

5. A method of claim 1, wherein the live attenuated hepatitis A virus is administered by percutaneous injection.

6. A method of claim 1, wherein live attenuated hepatitis A virus is administered by mouth.

7. An improved vaccine for mammals comprising a triple cloned hepatitis A virus, strain HM-175, that is useful after attenuation as a vaccine."

The cited passages of the text and claims were the same in the US priority document and in the PCT application published under number WO 86/01826 resulting in the present European application.

III. During further prosecution the appellant submitted new claims and also by letter dated 16 February 1987, received on 20 February 1987, a certificate from the American Type Culture Collection reading inter alia:

"Identification reference by depositor......ATCC designation

Hepatitis A Virus: Strain HM-175, Clone 5.........VR 2097 Hepatitis A Virus: Strain HM-175, Clone 6.........VR 2098 Hepatitis A Virus: Strain HM-175, Clone 7.........VR 2099

The deposits were received October 5, 1984 by this International Depositary Authority and have been accepted.

The strains will be made available if a patent office signatory to the Budapest Treaty certifies one's right to receive, or if a U.S. Patent is issued citing the strains.

..."

IV. The Examining Division issued a communication objecting to the claims then put forward on the grounds of lack of novelty and inventive step, in response to which 9 new claims were filed with letter of 2 February 1989, claim 1 of which read as follows:

"1. A uniform hepatitis A live attenuated virus composition adapted to produce a protective antibody response in higher primates, characterized in that the composition is triple cloned material of strain ATCC VR2097, VR2098, or VR2099."

A further communication objecting to this claim as contravening Article 123(2) EPC was issued and the appellant replied thereto.

V. In the decision under appeal the Examining Division refused the application on the basis of the claims filed with letter of 2 February 1989. The Examining Division came to the conclusion that the application did not meet the requirements of Article 123(2) EPC because the introduction of the information about the deposit numbers of three clones (VR2097, VR2098 and VR2099) constituted added subject-matter.

VI. The appellant appealed against this decision and filed a written statement setting out the grounds of appeal. With a letter dated 21 August 1991, the appellant filed a set of new claims 1 to 7, claims 1 and 6 of which read as follows:

"1. A uniform hepatitis A live attenuated virus composition adapted to produce a protective antibody response in higher primates, characterized in that the composition is triple cloned material of strain HM-175 (VR2093), in that the material is of a passage level of at least 10 to 30, and in that the triple cloning is effected by terminal dilution."

"6. A method for the production of a uniform hepatitis A live attenuated virus composition which comprises the step of serially diluting uncloned hepatitis A virus HM-175 (ATCC VR 2093), and inoculating each dilution into a respective mammalian cell culture, culturing the same, harvesting cloned virus particles and repeating said step at least twice more, thereby to produce a master seed lot therefrom for the formation of a vaccine composition."

An amended description was also filed at the same time, referring for the first time in the application proceedings to the HM-175 strain of hepatitis A virus being deposited in the American Type Culture Collection under the number ATCC VR 2093 on 14 August 1984.

VII. Board of Appeal 3.3.2 issued on 26 February 1993 interlocutory decision T 815/90 (OJ EPO 1994, 389), referring to the Enlarged Board of Appeal the question:

"May the information concerning the file number of a culture deposit according to Rule 28(1)(c) EPC be submitted after the expiry of the time limit set out in Rule 28(2)(a) EPC?"

VIII. By its decision G 0002/93 (OJ EPO 1995, 275) the Enlarged Board of Appeal answered this question as follows:

"The information concerning the file number of a culture deposit according to Rule 28(1)(c) EPC may not be submitted after expiry of the time limit set out in Rule 28(2)(a) EPC."

In point 14 of its decision it also commented "Whether the 'Guidelines for Examination in the EPO', Part A, Chapter IV, No. 4.2, a general practice of the EPO based thereupon or other special circumstances of the case may have given rise to legitimate expectations on the part of the appellant, to the effect that the time limit under Rule 28(2)(a) EPC could be extended, is left to the referring board of appeal to consider on the basis of supporting facts, evidence and arguments that may be submitted to it."

IX. The following further documents were submitted during the continuance of the appeal proceedings before the present Board 3.3.4:

- Mrs. Brandon's affidavit dated 14 June 1994

- ATCC deposit receipt dated 5 December 1995 (submitted at the oral proceedings) reading:

"Identification reference by depositor......ATCC designation

Hepatitis A Virus: Strain HM-175,.................VR 2093

HM-175 Pass 20 uncloned

The deposit was received August 14, 1984 by this International Depositary Authority and has been accepted.

AT YOUR REQUEST:

The strain is available to the scientific public upon request as of December 29, 1985.

The strains will be made available if a patent office signatory to the Budapest Treaty certifies one's right to receive, or if a U.S. Patent is issued citing the strains.

..."

- ATCC Catalogue of Animal Viruses and Antisera, Chlamydiae and Rickettsiae, 6th edition, pages 109 and 210 (1990).

X. In a communication accompanying the summons to oral proceedings, Board of Appeal 3.3.4 pointed out the most important points to be discussed at the oral proceedings. In response to this communication, the Applicant submitted new claims 1 to 11, of which claim 1 reads as follows:

"1. A live attenuated hepatitis A virus composition derived from any one of the following HM-175 hepatitis A viruses deposited at the American Type Culture Collection (ATCC):

A. uncloned HM-175, wherein the derivation of said composition includes triple cloning;

B. Clone No. 1;

C. Clone No. 2; and

D. Clone No. 4."

Oral proceedings were held on 18 February 1997, during which the appellant submitted, as first auxiliary request, claims 1 to 9. Claims 1 and 8 of this request read as follows:

"1. A live attenuated hepatitis A virus composition derived from uncloned HM-175 hepatitis A virus deposited at the American Type Culture Collection (ATCC), wherein the derivation of said composition includes triple cloning."

"8. A method for the production of a live attenuated hepatitis A virus composition which comprises the step of serially diluting a virus derived from uncloned HM-175 hepatitis A virus deposited at the ATCC and inoculating each dilution into a respective mammalian cell culture, culturing the same, harvesting cloned virus particles and repeating said step at least twice more, thereby to produce a master seed lot therefrom for the formation of a vaccine composition."

XI. In support of his requests, the appellant submitted essentially that the requirements of the second part of Rule 28(1)(c) relating to the accession number were satisfied and thus it did not amount to undue burden for a skilled person to obtain and identify the deposited material because:

- The ATCC maintained the cloned and uncloned deposits separate from each other and was able to identify the requested sample based on the depositor's designation (see Mrs. Brandon's affidavit)

- It was not decisive that the accession number be given because the depositor's designation is cross indexed (see ATCC Catalogue)

It was also argued that Rule 28 EPC in its previous version did not require the accession number and that the failure of the EPO to raise the deposit question within the time limit provided by Rule 28(2) conferred a legitimate expectation to the applicant that the application as filed satisfied the requirements of Rule 28(1) EPC.

XII. The appellant requested that the decision under appeal be set aside and that a patent be granted as main request on the basis of claims 1 to 11 and amended pages 2 and 2a filed with letter dated 17 January 1997, or as first auxiliary request, on the basis of the set of claims 1 to 9 submitted at the oral proceedings on 18. February 1997.

XIII. At the end of the oral proceedings after deliberation by the Board the chairwoman gave the following decision:

1. The debate on the issues discussed at the oral proceedings is closed.

2. The board will give its decision in due course in writing.

1. Main request

1.1. Article 123(2) EPC

1.1.1. The wording of Claim 1 of this request refers to live attenuated hepatitis A virus composition derived from one of the following HM-175 hepatitis A viruses deposited at the American Type Culture Collection (ATCC):

A. uncloned HM-175, wherein the derivation of said composition includes triple cloning;

B. Clone No. 1;

C. Clone No. 2; and

D. Clone No. 4;

To the original information in the application as filed, namely that the HM-175 strain of hepatitis A had been deposited in the American Type Culture Collection under the patent procedures, there is now added by newly filed page 2 (lines 1 to 2) the information that it was "under the designations: HM-175 uncloned, HM-175 clone #1, HM-175 clone #2 and HM-175 clone #4 on 14th August 1984".

1.1.2. While these identifications of the clones are mentioned in Example 3 as originally filed, and there is a reference before Example 1 to HM-175 imported into the USA, presumably uncloned, there is no clear and unambiguous disclosure in the application as originally filed that these particular clones were the ones referred to as deposited with the ATCC in the Statement of deposit in the originally filed description (see above, point II of the Facts and Submissions) or that the uncloned material is of passage 20 as now appears from the evidence submitted. The originally filed statement of deposit might with at least equal probability be taken as referring to unpassaged material.

1.1.3. That there is no clear basis for identifying the material now referred to as being that meant originally, is also evidenced by the actions of the appellant. Before the Examination Division the appellant was seeking to refer to other deposited material, namely HM-175 clones 5, 6 and 7.

1.1.4. This claim 1 does not comply with Article 123(2) EPC forbidding the addition of subject-matter not appearing in the application as filed.

1.2. Rule 28(2) EPC

1.2.1. The accession number of the depositary institution is not now stated in Claim 1. This avoids the problem that the accession number was not provided within the time limit set in Rule 28(a) EPC, which time limit the answer of the Enlarged Board in decision G 0002/93 has indicated as binding. However the omission of the any reference to the accession number raises an even worse problem, namely whether claim 1 can be regarded as relating to biological material deposited in accordance with Rule 28 EPC.

1.2.2. The appellant has argued that Rule 28 EPC requires only that the internal house reference number of the applicant be stated, not the file reference number of the depositary institution. This is not the case for Rule 28 EPC as now worded. Nor does the Board see that there was any doubt that under the previous wording of Rule 28 EPC the term "file number" referred to anything other than the file number of the depositary institution. At the time the original Rule 28 EPC was drafted "accession number" was not yet a standard term in treaties, but in its context the term "file number" could only refer to the file number of the depositary institution, as there would be no reason to give an applicant extra time to state his own in-house reference number. Further the appellant made his application pursuant to the Patent Cooperation Treaty and this in its Rule 13bis: Microbiological Inventions states:

"13bis.2 References (General)

Any reference to a deposited microorganism shall be made in accordance with this Rule and, if so made, shall be considered as satisfying the requirements of the national law of each designated State.

13bis.3 References: Contents; Failure to Include Reference or Indication

(a) A reference to a deposited microorganism shall indicate,

(i) the name and address of the depositary institution with which the deposit was made;

(ii) the date of deposit of the microorganism with that institution;

(iii) the accession number given to the deposit by that institution;..." (emphasis by the board)

Rule 13bis.4 requires the information to be provided within sixteen months of the priority date.

1.2.3. The Board sees no case for Rule 28 EPC providing a justification for the filing at a later date than the application any information other than an accession number in relation to material that has been deposited. The amendments put forward must thus be assessed for fair basis only on the text of the original application. As already concluded in Section 1.1 above there is no such basis.

1.3. Principle of legitimate expectations

1.3.1. There remains to be investigated whether in the circumstances some application of the principle of legitimate expectations could nevertheless be relied on to allow the claim 1 now put forward. However this principle has been used only to allow applicants to escape the consequences of not complying with procedural requirements or the payment of fees. Here the claim put forward is not acceptable under Article 123(2) EPC, and the Board cannot see its way to using this principle to allow the addition of subject-matter outside the ambit of Rule 28 EPC, which subject-matter is not fairly based on the original application.

1.3.2. The appellant relies on decision J 0008/87 of 30. November 1987 (OJ EPO 1989, 009) to support the application of the principle of legitimate expectations to this case. This decision, whose rationale has now been disapproved of by the Enlarged Board in its decision G 0002/93, was not published until some eighteen months after the filing date of the present application, too late to have been the cause of any misunderstanding. Not even any principle that applicants in similarly exceptional situations should be treated equally favourably, assists the appellant here. The applicant concerned in decision J 0008/87 had provided the accession number only two months out of time, and there was a single deposit clearly correlated with the description. Here the case is much worse, in that the appellant is seeking to introduce many years after the application date a reference to deposited material in a form not permitted by Rule 28 EPC. This is not something the Board can find any justification for, whether by reliance on the principle of legitimate expectations or otherwise.

1.3.3. The Board accordingly finds that the main request does not comply with Article 123(2) EPC.

2. First auxiliary request

2.1. Article 123(2) EPC

2.1.1. Claim 1 of this request is restricted as against Claim 1 of the main request to live attenuated hepatitis A virus composition derived from uncloned HM-175 hepatitis virus deposited at the American Type Culture Collection. However, as already stated in connection with Claim 1 of the main request, there is no clear and unambiguous disclosure in the application as originally filed that it was this material which was deposited. For the reasons stated above in connection with the main request, neither Rule 28 EPC nor the principle of legitimate expectations can serve to make this added subject-matter acceptable. The Board finds that the auxiliary request contravenes Article 123(2) EPC and is not allowable, and that the appeal must be dismissed.

3. Article 83 EPC

3.1. In view of the quantity of evidence filed the Board would remark that the requests were considered unacceptable also under Article 83 EPC, and whereas deletions of the added subject-matter referring to specific material having been deposited at the ATCC could have avoided the Article 123(2) EPC objection, the objection under Article 83 EPC would have remained. The claimed subject-matter cannot benefit from the provision of Rule 28(1) that deposited material is disclosed for the purposes of Article 83 EPC. The evidence shows that the subject-matter of the respective claims 1 was not in fact available to the public at the filing date of the application. Without the benefit of the deeming provision of Rule 28(1) EPC for duly deposited and timely identified biological material, the invention as claimed was not disclosed in a sufficiently complete manner to be carried out by a person skilled in the art. The Board wholly agrees with the comment by the Enlarged Board in its decision G 0002/93 that indication of the file number (accession number) is substantive because it is instrumental in enabling a person skilled in the art to carry out the invention. If Rule 28 EPC is not complied with, there can be no deemed compliance with the provisions of Article 83 EPC for deposited material. This deemed compliance is a special privilege conferred by Rule 28(1) EPC only on correctly and timely identified deposited material.

Order

ORDER

For these reasons it is decided that:

The appeal is dismissed.

Footer - Service & support
  • Service & support
    • Website updates
    • Availability of online services
    • FAQ
    • Publications
    • Procedural communications
    • Contact us
    • Subscription centre
    • Official holidays
    • Glossary
Footer - More links
  • Jobs & careers
  • Press centre
  • Single Access Portal
  • Procurement
  • Boards of Appeal
Facebook
European Patent Office
EPO Jobs
Instagram
EuropeanPatentOffice
Linkedin
European Patent Office
EPO Jobs
EPO Procurement
X (formerly Twitter)
EPOorg
EPOjobs
Youtube
TheEPO
Footer
  • Legal notice
  • Terms of use
  • Data protection and privacy
  • Accessibility